The major players in the renal anemia treatment market include Amgen Inc., ViforPharma Management Ltd., Hoffmann-La Roche Ltd., Pfizer Inc., Sandoz International GmbH (Novartis AG), Janssen Pharmaceuticals, Inc. (Johnson & Johnson), Teva Pharmaceutical Industries Ltd., AMAG Pharmaceuticals, Rockwell Medical, Akebia Therapeutics.
Changing lifestyles and unhealthy eating habits are the major drivers for the growth of the renal anaemia treatment market. increasing global population and the rising number of chronic diseases like kidney failure are some of the factors which can propel the growth of this market. Raising awareness about the novel treatment methods and a very selective number of drugs available to cure renal anaemia will further enhance market growth. The COVID-19 pandemic has no direct relationship with renal anaemia but people with chronic conditions have higher chances of contracting one due to the change in lifestyle introduced by the lockdown. The key constraints of this market are high treatment costs and the side effects associated.
The entire renal anemia treatment market has been sub-categorized into medicine type, route of administration and distribution channel. current and future demand for renal anemia treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
By Medicine Type
- Iron Supplements
- Erythrocyte Stimulating Agents
- Red Blood Cell Transfusions
- Vitamin B 12 and Folic Acid Supplements
By Route of Administration
- Oral
- Parenteral
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Source: https://www.valuemarketresearch.com/report/renal-anemia-treatment-market
Naira Shekhawat has been into Content Writing just after completing her Graduation in English Literature. Her love for words has won her many accolades in her respective jobs ever since. Naira covers business sections for VMR News. She is a traveller by heart and loves writing on food blogs as a freelancer.